Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by buddyboybruceon Jul 08, 2022 2:18pm

161 Views

Post# 34811619

Omicron variant Covid-19 --- TSX:MBX

How much of the December 2021 runup for MBX, up to 86 cents, was based on the Omicron scare at Christmas?
If there is a new variant that causes a huge demand for testing, say starting in September outbreak for example, will MBX runup again. I know MBX is not a Covid stock, but it sort of seems to be behaving like one ever since 2020.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security